With a new key hire, the Napster cofounder’s cancer fighting non-profit is ready to back the science both governments and ...

Judging by the present cost of production at the clinical research stage, Cheng, who previously worked as a biological ...

Corcept Therapeutics’ oral antiglucocorticoid plus chemotherapy slashed risk of ovarian cancer progression by 30% compared to ...

Cologuard is getting an upgrade after 10 years on the market, as Exact Sciences starts to roll out the new version of its ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Karen Knudsen has accepted a new post six months after announcing her decision to step down as CEO of the American Cancer ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new ...

The Boston biotech is also looking into "strategic options" after its only clinical-stage drug showed disappointing Phase 1 ...

STAT reporters discuss the layoffs and reorganization of HHS, data privacy concerns following 23andMe's bankruptcy filing, ...